Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04311749 · ClinicalTrials.gov registry record
Expanded NIPT for Pregnancy Complications
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 70
- Enrollment target
NCT04311749 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 70 participants.
The verdict
NCT04311749 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
Study Summary
This study evaluates the utility of expanded panel non-invasive prenatal testing (NIPT) in detecting confined placental mosaicism of rare autosomal trisomies among pregnancies with placentally-mediated complications, including fetal growth restriction and severe preeclampsia.
Interventions
- GENETIC Expanded panel cell free DNA testing (non-invasive prenatal testing)
- GENETIC Placental biopsy
- GENETIC Umbilical cord blood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2020-02-12 |
| Est. Completion | 2024-08-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04311749
The ClinicalTrials.gov registry entry for NCT04311749 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Expanded panel cell free DNA testing (non-invasive prenatal testing) is the first listed.
NCT04311749 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04311749 about?
NCT04311749 is a clinical study titled "Expanded NIPT for Pregnancy Complications". This study evaluates the utility of expanded panel non-invasive prenatal testing (NIPT) in detecting confined placental mosaicism of rare autosomal trisomies among pregnancies with placentally-mediated complications, including fetal growth restriction and severe preeclampsia.
What is the current status of trial NCT04311749?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2020-02-12. Estimated completion is 2024-08-30.
What interventions are being tested in trial NCT04311749?
The interventions under investigation include: Expanded panel cell free DNA testing (non-invasive prenatal testing) (GENETIC), Placental biopsy (GENETIC), Umbilical cord blood (GENETIC).
Who is sponsoring clinical trial NCT04311749?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.